Search by Drug Name or NDC
NDC 68703-0315-30 Migo-Ease 30; 6; 6; 6; 6 [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1 Details
Migo-Ease 30; 6; 6; 6; 6 [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1
Migo-Ease is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Silver Star Brands. The primary component is ACONITUM NAPELLUS; LYCOPODIUM CLAVATUM SPORE; PULSATILLA VULGARIS; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED.
Product Information
| NDC | 68703-0315 |
|---|---|
| Product ID | 68703-315_f61eec61-48ba-a3cb-e053-2995a90a7db2 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Migo-Ease |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Aconitum nap, Lycopodium, Nat mur, Nux vom, Pulsatilla |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 30; 6; 6; 6; 6 |
| Active Ingredient Units | [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1; [hp_C]/1 |
| Substance Name | ACONITUM NAPELLUS; LYCOPODIUM CLAVATUM SPORE; PULSATILLA VULGARIS; SODIUM CHLORIDE; STRYCHNOS NUX-VOMICA SEED |
| Labeler Name | Silver Star Brands |
| Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Non-Standardized Plant Allergenic Extract |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED HOMEOPATHIC |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68703-0315-30 (68703031530)
| NDC Package Code | 68703-315-30 |
|---|---|
| Billing NDC | 68703031530 |
| Package | 180 TABLET in 1 BOTTLE, GLASS (68703-315-30) |
| Marketing Start Date | 2018-12-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |